Indian pharmaceutical giant Glenmark Pharmaceuticals Inc. has broadened its U.S. market presence by introducing a new generic treatment for glaucoma. https://www.healthcaremea.com/glenmark-expands-us-ophthalmic-portfolio-with-new-glaucoma-drug/